Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon Mar 26, 2021 9:24am
168 Views
Post# 32885090

I know it's fun and purposeful to update fellas ; - )

I know it's fun and purposeful to update fellas ; - )Howbout that CV19 trial we're running here in the US?  You know the one that added a site and is now less than a month away from the 1 year mark.

The trial was set to look at 75 patients...I'm disapointed beacause I bet Cliff the barber $20 ( or my next cut for free ) that we would have "recruited stunted" due to covid19

Where is the update on this?  Last August the FDA called for an additional site...

We can't close the deal on the friendly wager without confirmation
<< Previous
Bullboard Posts
Next >>